Validation of a Deficit-Accumulation Frailty Index in the ASPirin in Reducing Events in the Elderly Study and Its Predictive Capacity for Disability-Free Survival is a research paper published in The Journals of Gerontology Series A (2021). On theSindex it has a DataRank of 0. It has been cited 54 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: U01AG029824
National Cancer Institute
Grant: U19AG062682
National Health and Medical Research Council
Grant: 334047
Randomised double-blind placebo-controlled trial of aspirin in primary prevention of CVD events or dementia in the aged.
National Health and Medical Research Council
Grant: 1127060
ASPREE Completion Project
NHMRC Dementia Research Leader Fellowship
Grant: 1135727
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Development and validation of a physical frailty phenotype index-based model to estimate the frailty index
Additional file 1 of Development and validation of a physical frailty phenotype index-based model to estimate the frailty index
Additional file 1 of Prediction of adverse health outcomes using an electronic frailty index among nonfrail and prefrail community elders
Additional file 1 of Prediction of adverse health outcomes using an electronic frailty index among nonfrail and prefrail community elders
Additional file 2 of Prediction of adverse health outcomes using an electronic frailty index among nonfrail and prefrail community elders
Additional file 2 of Prediction of adverse health outcomes using an electronic frailty index among nonfrail and prefrail community elders